
Drugs IPOs Depend o...


| Price and Volume | |
|---|---|
| Recent Price | 13.41 |
| 52 Week High | 17.50 |
| 52 Week Low | 13.12 |
| Avg. Daily Vol. (Mil) | 0.09 |
| Beta (3 year) | 0.43 |
| Share Related Items | |
| Mkt Cap (Mil) | 3,514.77 |
| Shares Out (Mil) | 262.10 |
| Float (Mil) | 217.68 |
| Dividend Information | |
| Yield % | 8.30 |
| Annual Dividend | 1.11 |
| Payout Ratio | n.a. |
| Financial Strength | |
| Quick Ratio | 0.40 |
| Current Ratio | 0.60 |
| LT Debt/ Equity | 1.64 |
| Total Debt / Equity | 1.93 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.66 |
| Price/Book | 1.62 |
| Price/Cash Flow | -41.60 |
| Per Share Data | |
| Earnings | -2.97 |
| Sales | 8.10 |
| Book Value | 8.27 |
| Cash Flow | -0.32 |
| Business Summary | |
|---|---|
| TransAlta Corporation is a wholesale power generator and marketer with operations in Canada, the United States and Australia. | |
| General Information | |
| 110 - 12th Avenue SW
Box 1900, Station M Calgary, AB T2P 2M1 |
|
| www.transalta.com | |
| Industry : Utilities | |
| Sector: Utilities | |
| Employees: 2084 | |
| CEO: Dawn L. Farrell | |
| Short Interest | |
| Current Month (Mil) | 3.69 |
| Previous Month (Mil) | 2.97 |
| Short Interest Ratio (Days) | 39.80 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -6.80 |
| Return on Investments | -9.60 |
| Profitability | |
| Gross Margin | 42.20 |
| EBIT Margin | -14.20 |
| Profit Margin | -29.40 |